Clinical Trials Directory

Trials / Unknown

UnknownNCT00959491

A Prospective Study of a New Immunological Fecal Occult Blood Test

A Prospective Study of a New Immunological Fecal Occult Blood Test in Patients Referred for Colonoscopy

Status
Unknown
Phase
Study type
Observational
Enrollment
160 (estimated)
Sponsor
National Institute of Gastroenterology, Cuba · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of the investigators study is to evaluate the diagnostic ability of a new immunological fecal occult blood test in Cuban patients undergoing colonoscopy .

Detailed description

Colorectal cancer is a major cause of cancer deaths in many countries. Therefore, the importance of screening for the early detection of colorectal cancer is evident. Fecal occult blood screening is proving to be an effective tool for detecting premalignant adenomas and colon cancer since the guaiac-based test was introduced in the late 1960s. However, several immunochemical fecal occult blood tests (IFOBTs) have become commercially available and the majority of these have demonstrated equal or superior sensitivities and specificities than the guaiac-based tests. Therefore, IFOBTs are replacing guaiac based tests despite their higher costs.In this study we evaluate the diagnostic accuracy of a new IFOBT and compare with the findings on colonoscopy.

Conditions

Timeline

Start date
2009-10-01
Primary completion
2010-10-01
Completion
2010-11-01
First posted
2009-08-14
Last updated
2010-10-20

Locations

1 site across 1 country: Cuba

Source: ClinicalTrials.gov record NCT00959491. Inclusion in this directory is not an endorsement.